⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7634738 | 0.80 | — | — | |
| SCHEMBL2065723 | 0.79 | — | — | |
| SCHEMBL15527760 | 0.78 | — | — | |
| SCHEMBL28885792 | 0.74 | — | — | |
| SCHEMBL2170086 | 0.72 | — | — | |
| SCHEMBL1837501 | 0.72 | MAPT (0.31) | — | |
| SCHEMBL418569 | 0.71 | THRB (0.41) | — | |
| SCHEMBL2340826 | 0.71 | THRB (0.41) | — | |
| SCHEMBL11207343 | 0.69 | TSHR (0.42) | — | |
| SCHEMBL31288 | 0.69 | SCN2A (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7322694-B2 | Hybrid contact lens system and method | SYNERGEYES, INC. (US) | 2008-01-29 | — | — | US | claimed |
| CN-1930513-A | Hybrid contact lens system and method | QUARTER LAMBDA TECHNOLOGIES IN (US) | 2007-03-14 | — | — | CN | claimed |
| EP-1714182-A2 | HYBRID CONTACT LENS SYSTEM AND METHOD | Quarter Lambda Technologies Inc. (US) | 2006-10-25 | — | — | EP | claimed |
| WO-2005079290-A2 | HYBRID CONTACT LENS SYSTEM AND METHOD | SYNERGEYES, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050018130-A1 | Hybrid contact lens system and method | SYNERGEYES, INC. | 2005-01-27 | — | — | US | claimed |
| US-7585074-B2 | Hybrid contact lens system and method | SYNERGEYES, INC. (US) | 2009-09-08 | — | — | US | disclosed |
| US-7401922-B2 | Method and apparatus for reducing or eliminating the progression of myopia | SYNERGEYES, INC. (US) | 2008-07-22 | — | — | US | disclosed |
| US-7322694-B2 | Hybrid contact lens system and method | SYNERGEYES, INC. (US) | 2008-01-29 | — | — | US | disclosed |
| CN-1930513-A | Hybrid contact lens system and method | QUARTER LAMBDA TECHNOLOGIES IN (US) | 2007-03-14 | — | — | CN | disclosed |
| US-20070013869-A1 | HYBRID CONTACT LENS SYSTEM AND METHOD | DAHI ALI | 2007-01-18 | — | — | US | disclosed |
| US-7163292-B2 | Hybrid contact lens system and method | SYNERGEYES, INC. (US) | 2007-01-16 | — | — | US | disclosed |
| US-20060285072-A1 | Hybrid contact lens system and method | DAHI ALI | 2006-12-21 | — | — | US | disclosed |
| WO-2006113149-A2 | METHOD AND APPARATUS FOR REDUCING OR ELIMINATING THE PROGRESSION OF MYOPIA | SYNERGEYES, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| EP-1714182-A2 | HYBRID CONTACT LENS SYSTEM AND METHOD | Quarter Lambda Technologies Inc. (US) | 2006-10-25 | — | — | EP | disclosed |
| US-20060232743-A1 | Method and apparatus for reducing or eliminating the progression of myopia | SYNERGEYES, INC. | 2006-10-19 | — | — | US | disclosed |
| US-7104648-B2 | Hybrid contact lens system and method | SYNERGEYES, INC. (US) | 2006-09-12 | — | — | US | disclosed |
| WO-2005079290-A2 | HYBRID CONTACT LENS SYSTEM AND METHOD | SYNERGEYES, INC. (US) | 2005-09-01 | — | — | WO | disclosed |
| US-20050018130-A1 | Hybrid contact lens system and method | SYNERGEYES, INC. | 2005-01-27 | — | — | US | disclosed |
| US-20040212779-A1 | Hybrid contact lens system and method | SYNERGEYES, INC. | 2004-10-28 | — | — | US | disclosed |
| US-20040179167-A1 | Hybrid contact lens system and method | SYNERGEYES, INC. | 2004-09-16 | — | — | US | disclosed |